ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Supercomputer Upgrading Supported By DCBD Board; Could Cost $40 Million Plus Renovations

March 3, 1989

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003